Relay Therapeutics RLAY
NASDAQ RLAY
$19.92 -0.02 (-0.10%)
As of: Nov 11, 2026 · 10:29 AM EST

Relay Therapeutics (RLAY) Accumulated Expenses (2019 - 2026)

Updated

Relay Therapeutics (RLAY) posted Accumulated Expenses of $34.08 million for Q2 2026, up 46.8% from $23.22 million a year earlier and up 63.0% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Relay Therapeutics' Accumulated Expenses came in at $13.65 million, down 35.7% from FY2024.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
  • In prior years, Relay Therapeutics' Accumulated Expenses was $21.24 million in FY2024 (+42.6%), $14.89 million in FY2023 (-34.4%), $22.7 million in FY2022 (+67.5%) and $13.56 million in FY2021 (+135.4%).
  • The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2019.
  • On a year-over-year basis, Accumulated Expenses increased in three of the last eight quarters, with growth averaging 1.5%.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q4 2021, with growth of 135.4%; the weakest was Q4 2025, with a decline of 35.7%.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $20.91 million (Q1 2026), $13.65 million (Q4 2025) and $25.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Relay Therapeutics 4.38 Bn 3.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 45.06 Mn
Jun 30, 2026 34.08 Mn
Mar 31, 2026 20.91 Mn
Dec 31, 2025 13.65 Mn
Sep 30, 2025 25.13 Mn
Jun 30, 2025 23.22 Mn
Mar 31, 2025 20.99 Mn
Dec 31, 2024 21.24 Mn
Sep 30, 2024 33.22 Mn
Jun 30, 2024 27.77 Mn
Mar 31, 2024 22.36 Mn
Dec 31, 2023 14.89 Mn
Sep 30, 2023 31.49 Mn
Jun 30, 2023 26.91 Mn
Mar 31, 2023 28.05 Mn
Dec 31, 2022 22.70 Mn
Sep 30, 2022 29.36 Mn
Jun 30, 2022 22.11 Mn
Mar 31, 2022 15.22 Mn
Dec 31, 2021 13.56 Mn
API Access

Relay Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RLAY&period=max&api_key=YOUR_API_KEY